Linezolid solution for infusion, 2 mg/ml, 300 ml; Imipenem/Celastatin 500mg/500mg powder for solution for infusion; Doxycycline capsules/tablets, 100 mg; Ofloxacin, solution for infusion, 2 mg/ml, 100 ml; Piperacillin/tazobactam, powder (lyophilisate) for … I will solution, 4 g/0.5 g each. (INN: Linezolid, ATX: J01XX08; INN: Imipenem and cilastatin, ATX: J01DH51; INN: Doxycycline, ATX: J01AA02; INN: Ofloxacin, ATX: J01MA01; INN: Piperacillin and beta-lactamase inhibitor, ATX: J01CR05). (Nomenclature position code: DK 021:2015 33650000-1 “General anti-infectives for systemic use, vaccines, antineoplastic agents and immunomodulators”; DK 021:2015 33650000-1 “General anti-infectives for systemic use, vaccines, antineoplastic agents and immunomodulators”; DK 021:2015 33650000-1 “General anti-infectives for systemic use, vaccines, antineoplastic agents and immunomodulators”; DK 021:2015 33650000-1 “General anti-infectives for systemic use, vaccines, antineoplastic agents and immunomodulators”; DK 021:2015 33650000-1 “General anti-infectives for systemic use, vaccines, antineoplastic agents and immunomodulators")